candesartan cilexetil has been researched along with Infarct in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mackenzie, HS | 1 |
| Troy, JL | 1 |
| Rennke, HG | 1 |
| Brenner, BM | 1 |
1 other study available for candesartan cilexetil and Infarct
| Article | Year |
|---|---|
TCV 116 prevents progressive renal injury in rats with extensive renal mass ablation.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Hemod | 1994 |